Statsols recently hosted a guest lecture by Professor Stephen Senn of the Luxembourg Institute of Health.
Prof. Senn spoke about:
'Response, Quality and Variation - What Drug Development May Be Missing'
The pharmaceutical industry has both made a success and a failure of dealing with variation. It has become adept at designing trials that can deliver good signals against a background of variation. However, too often it has accepted measurement approaches that increase the variation and has done much less well in understanding that variation.
Amongst the side-effects, has been an overestimate of the scope for personalizing medicine. In this lecture Senn will claim that one of the lost opportunities of studying the effects of treatment has been using intelligent statistical approaches to decomposing variance and, in order to do better, that we should pay close attention to what others have been doing to try and tame variation in health care delivery.
The content of this lecture will appeal to both a scientific & clinical research audience, as well as to a statistical audience. To watch this lecture on demand, simply complete the onpage form.
About Professor Stephen Senn
Currently Head of Competence Centre for Methodology and Statistics with the Luxembourg Institute of Health, Stephen Senn was previously Professor of Statistics at a number of UK universities as well as holding senior statistical roles in the Swiss pharmaceutical industry.
He has written numerous papers in the area of healthcare statistics, and three books; Statistical Issues in Drug Development (Wiley: 1997,2007), Dicing with Death (Cambridge: 2003) and Crossover Trials in Clinical Research (Wiley: 1993,2002).
He is recognized as a leading global authority on clinical biostatistics. Stephen Senn is a former member of the Statsols statistical advisory board and he currently serves as a consultant to our statistical development team.